These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 982733)

  • 1. Doxorubicin hydrochloride, cyclophosphamide, and 5-fluorouracil combination in advanced prostate and transitional cell carcinoma.
    Collier D; Soloway MS
    Urology; 1976 Nov; 8(5):459-64. PubMed ID: 982733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase II evaluation of a 3-drug combination of cyclophosphamide, doxorubicin and 5-fluorouracil and of 5-fluorouracil in patients with advanced bladder carcinoma or stage D prostatic carcinoma.
    Smalley RV; Bartolucci AA; Hemstreet G; Hester M
    J Urol; 1981 Feb; 125(2):191-5. PubMed ID: 7206052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy of advanced carcinoma of the prostate with 5-fluorouracil, cyclophosphamide and adriamycin.
    Merrin C; Etra W; Wajsman Z; Baumgartner G; Murphy G
    J Urol; 1976 Jan; 115(1):86-8. PubMed ID: 1107604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of adriamycin (NSC-123127) and the combination of 5-fluorouracil (NSC-19893) and cyclophosphamide (NSC-26271) in advanced prostatic cancer: a preliminary report.
    Eagan RT; Utz DC; Myers RP; Furlow WL
    Cancer Chemother Rep; 1975; 59(1):203-7. PubMed ID: 1093666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The treatment of advanced carcinoma of the bladder with combination chemotherapy.
    McGeorge A; Hart AJ; Rundle JS; McVie JG; Calman KC
    Br J Urol; 1982 Aug; 54(4):366-8. PubMed ID: 7052188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adriamycin (NSC-123127) versus 5-fluorouracil (NSC-19893) and cyclophosphamide (NSC-26271) in the treatment of metastatic prostate cancer.
    Eagan RT; Hahn RG; Myers RP
    Cancer Treat Rep; 1976 Jan; 60(1):115-7. PubMed ID: 1000515
    [No Abstract]   [Full Text] [Related]  

  • 7. Combination chemotherapy (CISCA) for advanced urinary tract carcinoma. A preliminary report.
    Sternberg JJ; Bracken RB; Handel PB; Johnson DE
    JAMA; 1977 Nov; 238(21):2282-7. PubMed ID: 578848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy of bladder carcinoma with cyclophosphamide and adriamycin.
    Merrin C; Cartagena R; Wajsman Z; Baumgartner G; Murphy GP
    J Urol; 1975 Dec; 114(6):884-7. PubMed ID: 1195468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination chemotherapy including adriamycin for advanced transitional cell carcinoma of the urinary tract.
    Kotake T; Usami M; Miki T; Kuroda M; Obata K; Osafune M; Fujioka H; Takasugi Y
    Cancer Chemother Pharmacol; 1983; 11 Suppl():S38-42. PubMed ID: 6685580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single and combination chemotherapy for primary murine bladder cancer.
    Soloway MS
    Cancer; 1975 Aug; 36(2):333-40. PubMed ID: 1157004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of advanced bladder cancer with adriamycin and 5-fluorouracil.
    Cross RJ; Glashan RW; Humphrey CS; Robinson RG; Smith PH; Williams RE
    Br J Urol; 1976; 48(7):609-15. PubMed ID: 1016834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative clinical trial of adriamycin and 5-fluorouracil in advanced prostatic cancer: prognostic factors and response.
    DeWys WD; Begg CB; Brodovsky H; Creech R; Khandekar J
    Prostate; 1983; 4(1):1-11. PubMed ID: 6340081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclophosphamide (NSC 26271) versus the combination of adriamycin (NSC 123127), 5-fluorouracil (NSC 19893), and cyclophosphamide in the treatment of metastatic prostatic cancer: a randomized trial.
    Chlebowski RT; Hestorff R; Sardoff L; Weiner J; Bateman JR
    Cancer; 1978 Dec; 42(6):2546-52. PubMed ID: 365313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination chemotherapy of advanced endometrial adenocarcinoma with adriamycin, cyclophosphamide, 5-fluorouracil, and medroxyprogesterone acetate.
    Bruckner HW; Deppe G
    Obstet Gynecol; 1977 Jul; 50(1 Suppl):10s-12s. PubMed ID: 876531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doxorubicin hydrochloride (adriamycin) in irradiated patients with advanced transitional cell carcinoma.
    Jacobo E; Weinstein SH; Schmidt JD; Culp DA
    Urology; 1976 Jul; 8(1):28-30. PubMed ID: 941355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arterial infusion of 5-FU as a therapeutic adjunct in the treatment of advanced carcinoma of bladder and prostate.
    Nevin JE; Melnick I; Baggerly JT; Landes R; Easley CA
    Va Med Mon (1918); 1975 Aug; 102(8):614-20. PubMed ID: 1163099
    [No Abstract]   [Full Text] [Related]  

  • 17. Cyclophosphamide, doxorubicin hydrochloride and 5-fluorouracil in advanced carcinoma of the prostate.
    Soloway MS; Shippel RM; Ikard M
    J Urol; 1979 Nov; 122(5):637-9. PubMed ID: 501816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclophosphamide versus 5-fluorouracil, doxorubicin, and mitomycin C (FAM') in the treatment of hormone-resistant metastatic carcinoma of the prostate: a preliminary report of a randomized trial.
    Kasimis BS; Miller JB; Kaneshiro CA; Forbes KA; Moran EM; Metter GE
    J Clin Oncol; 1985 Mar; 3(3):385-92. PubMed ID: 3838343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intra-arterial chemotherapy of patients in the late stages of bladder cancer].
    Dunchik VN; Drozdovskiĭ BIa; Kariakin OB; Grishin GN
    Urol Nefrol (Mosk); 1985; (2):19-23. PubMed ID: 3992752
    [No Abstract]   [Full Text] [Related]  

  • 20. Combination chemotherapy for advanced bladder cancer with adriamycin, cyclophosphamide, and 5-fluorouracil.
    Tashiro K; Machida T; Masuda F; Ohishi Y
    Cancer Chemother Pharmacol; 1983; 11 Suppl():S43-6. PubMed ID: 6640834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.